EXELIXIS, INC.
NASDAQ: EXEL
▼
23.73
-0.06
-0.23%
1 Day
-
Open
23.76
-
Previous Close
23.78
-
Volume (Avg)
2.17M (2.68M)
-
Day's Range
23.43-24.23
-
52Wk Range
13.67-27.80
-
Market Cap.
7.79B
-
Dividend Rate ( Yield)
-
-
Beta
1.12
-
Shares Outstanding
309.00M
-
P/E Ratio (EPS)
49.69 (0.48)
Top Stories
-
Exelixis (EXEL) Reports Preliminary Q4 Results, Business Updates
Zacks.com 5 days ago -
Calithera (CALA) Plunges as CANTANA Study on Telaglenastat Fails
Zacks.com -
Evaluating Exelixis
Seeking Alpha -
FY2020 Earnings Forecast for Exelixis, Inc. (NASDAQ:EXEL) Issued By Piper Sandler
theenterpriseleader.com -
Exelixis, Inc. Forecasted to Earn FY2022 Earnings of $1.24 Per Share (NASDAQ:EXEL)
modernreaders.com 2 days ago -
Exelixis, Inc. to Post Q1 2021 Earnings of $0.02 Per Share, Piper Sandler Forecasts (NASDAQ:EXEL)
modernreaders.com -
Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For ...
Business Wire -
Exelixis Announces Preliminary Fourth Quarter and...
Benzinga.com -
Exelixis (EXEL) Reports Preliminary Q4 Results, Business Updates
Nasdaq -
Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application
The Bakersfield Californian -
Interesting EXEL Put And Call Options For March 19th
Nasdaq -
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in December
Morningstar%2c Inc. -
Exelixis Inc. Equal Weight
Business Insider -
Exelixis Inc.
Barron's -
Exelixis Market Cap:
YCharts 1/8/2021Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When ...
-
Exelixis PE Ratio (Forward)
YCharts -
EXEL: Raising target price to $22.00
Yahoo Finance -
ZYME Jul 2021 55.000 put
Yahoo Finance
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A284ADB1542BC644D0753D4D443EE6530%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%2750e38818-66f0-4191-880a-10f660b75fc5%27&-ver=%271.0%27&-impressionGuid=%2750e38818-66f0-4191-880a-10f660b75fc5%27&-pageName=%27stocksummary%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-us%252Fmoney%252Fstockdetails%252Ffi-a1shp2%253Fsymbol%253DUS%253AEXEL%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"data"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"50e3881866f04191880a10f660b75fc5"%2C"clid"%3A"284ADB1542BC644D0753D4D443EE6530"%2C"clidType"%3A"muid"%2C"di"%3A"7290"%2C"partner"%3A"Thomson%2BReuters"%2C"publcat"%3A"Thomson%2BReuters%252c%2BLLC"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"a1shp2"%2C"entitySrc"%3A"fi"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"stockdetails"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-us%27){kind=small}